The Department of Defense Combat Casualty Care Research Program is sponsoring a consensus meeting on Emergency Transfusion in Females with Childbearing Potential: Mitigating the Risks of Hemolytic Disease of the Fetus and Newborn. The two-day meeting will take place at the Hyatt Regency in Bethesda, Maryland on Nov. 19 and 20, 2024. The first day is open to the public, while the second is reserved for expert panel voting. To register for the event, visit here External link.

The study is being conducted by the University of Pittsburgh, in cooperation with the Transfusion, Hemostasis and Oxygen Research Network and the AlloHope Foundation.It aims to create a multidisciplinary consensus statement for national recommendations focused on optimal transfusion strategies for females of childbearing potential who are at risk of experiencing life- threatening hemorrhage, as well as on screening and treatment recommendations to reduce the risk of hemolytic disease of the fetus and newborn, commonly referred to as HDFN.Several professional medical organizations and other stakeholders are participating in the study.Following the development of a consensus statement, the study's organizers will develop educational materials for at-risk women and their medical providers.